Key Messages From DCP3, Volume 4: Mental, Neurological, and Substance Use Disorders
2016
This review article from The Lancet summarizes the analyses from volume four of Disease Control Priorities, 3rd edition (DCP3), published by the World Bank, entitled “Mental, Neurological, and Substance Use Disorders.” That volume discusses the prevalence of mental, neurological, and substance use (MNS) disorders, as well as the associated disability and premature mortality that can accompany them. In this article, the authors describe the myriad effective interventions, including drugs, psychological treatments, and social interventions, that are available to prevent and treat MNS disorders, and identify population-, community-, and health-care level best practices for service delivery. They argue that achieving health gains associated with prioritized MNS interventions will require both financial investment as well as committed and sustained efforts to address a range of other barriers, including paucity of human resources, weak governance, and social stigma.
Key Messages From DCP3, Volume 4: Mental, Neurological, and Substance Use Disorders
Source:
Patel V et al. Addressing the Burden of Mental, Neurological, and Substance Use Disorders: Key Messages From Disease Control Priorities, 3rd Edition. The Lancet 2016; 387(10028): 1672–1685. DOI: https://doi.org/10.1016/S0140-6736(15)00390-6.